Skip to main content

Table 2 Unadjusted odds ratios from regression analyses of clinical outcome measures by disease classification* (compared to baseline group of patients with CVD and lung cancer)

From: Characteristics of people diagnosed with dementia vs lung cancer and cardiovascular disease at commencement of community palliative care: a population–based study

 

Dementia

(mean ± SD)

Median(IQR)

CVD

(mean ± SD)

Median(IQR)

Lung cancer

(mean ± SD)

Median(IQR)

Unadjusted OR

(95% CI)

(Dementia vs CVD)#

Unadjusted OR

(95% CI)

(Dementia vs lung caner)#

AKPS (range: 0—100)

29.09 ± 13.73

30 (20—40)

41.05 ± 15.96

40 (30—50)

55.49 ± 14.63

60 (50—70)

4.34

(4.05 – 4.63, < 0.001)

30.42

(28.42 – 32.56, < 0.001)

RUG – ADL

 Total score (range: 4–18)

16.03 ± 3.40

18 (15—18)

11.15 ± 5.32

11 (5—17)

6.38 ± 3.86

4 (4—8)

7.21

(6.76 – 7.68, < 0.001)

57.10

(53.43 – 61.02, < 0.001)

 Eating (range:1—3)

2.60 ± 0.68

3 (2—3)

1.76 ± 0.83

2 (1 – 3)

1.23 ± 0.52

1 (1—1)

7.54

(7.05 – 8.05, < 0.001)

42.55

(39.80 – 45.49, < 0.001)

 Toileting (range:1—5)

4.54 ± 0.90

5 (4—5)

3.22 ± 1.58

3 (1—5)

1.77 ± 1.26

1 (1—3)

6.73

(6.31 – 7.17, < 0.001)

50.58

(47.46 – 53.90, < 0.001)

 Bed Mobility (range:1—5)

4.39 ± 1.13

5 (4—5)

2.98 ± 1.67

3 (1—5)

1.59 ± 1.17

1 (1—1)

6.28

(5.89 – 6.70, < 0.001)

46.96

(44.01 – 50.10, < 0.001)

 Transfer (range:1—5)

4.51 ± 0.96

5 (4—5)

3.23 ± 1.58

3 (1—5)

1.79 ± 1.27

1 (1—3)

6.39

(5.99 – 6.81, < 0.001)

46.30

(43.44 – 49.35, < 0.001)

PCPSS (range: 0—3)

 Pain

0.70 ± 0.71

1 (0—1)

0.73 ± 0.75

1 (0—1)

0.89 ± 0.76

1 (0—1)

0.95

(0.90—1.01, = 0.098)

0.64

(0.61 – 0.67, < 0.001)

 Other symptoms

0.83 ± 0.74

1 (0—1)

1.16 ± 0.75

1 (1—2)

1.20 ± 0.70

1 (1—2)

0.42

(0.39 – 0.45, < 0.001)

0.34

(0.32 – 0.36, < 0.001)

 Psychological

0.53 ± 0.67

0 (0—1)

0.81 ± 0.71

1 (0—1)

0.92 ± 0.69

1 (0—1)

0.46

(0.43 – 0.48, < 0.001)

0.31

(0.29 – 0.32, < 0.001)

 Family

1.03 ± 0.77

1 (0—2)

1.11 ± 0.75

1 (1—2)

1.03 ± 0.73

1 (1 – 1)

0.81

(0.76 – 0.86, < 0.001)

0.96

(0.91 – 1.01, = 0.16)

SAS (range:0–10)

 Pain

1.57 ± 1.84

1 (0—3)

1.68 ± 2.02

1 (0—3)

2.12 ± 2.27

2 (0—3)

0.96

(0.90 – 1.02, = 0.16)

0.66

(0.63 – 0.69, < 0.001)

 Fatigue

1.35 ± 2.13

0 (0—2)

2.85 ± 2.57

3 (0—5)

3.31 ± 2.42

3 (2—5)

0.27

(0.25 – 0.29, < 0.001)

0.16

(0.15 – 0.17, < 0.001)

 Breathing problems

0.57 ± 1.30

0 (0—0)

2.48 ± 2.40

2 (0—4)

2.49 ± 2.37

2 (0—4)

0.13

(0.12 – 0.14, < 0.001)

0.12

(0.11 – 0.13, < 0.001)

 Bowel symptoms

0.88 ± 1.57

0 (0—1)

1.04 ± 1.70

0 (0—2)

1.19 ± 1.84

0 (0—2)

0.78

(0.73 – 0.84, < 0.001)

0.67

(0.63 – 0.70, < 0.001)

 Nausea

0.20 ± 0.83

0 (0 – 0)

0.51 ± 1.31

0 (0—0)

0.68 ± 1.49

0 (0—1)

0.35

(0.32 – 0.39, < 0.001)

0.25

(0.23 – 0.27, < 0.001)

 Appetite

1.07 ± 1.88

0 (0—2)

1.45 ± 2.05

0 (0—2)

1.83 ± 2.20

1 (0—3)

0.61

(0.57 – 0.65, < 0.001)

0.42

(0.40—0.45, < 0.001)

 Insomnia

0.62 ± 1.43

0 (0—0)

1.36 ± 2.06

0 (0—2)

1.41 ± 2.06

0 (0—2)

0.38

(0.35 – 0.41, < 0.001)

0.35

(0.33 – 0.37, < 0.001)

  1. Abbreviations: CVD Cardiovascular disease, LC lung cancer, SD Standard deviation, IQR interquartile range, AKPS Australian-modified Karnofsky Performances Status, RUG-ADL Resource Utilisation Group-Activities for Daily Living, PCPSS Palliative Care Problem Severity Score, SAS Symptom Assessment Scale, vs. versus
  2. # Significant findings (p < 0.05) in bold
Back to article page

BMC Palliative Care

ISSN: 1472-684X

Contact us